Cibus, Inc. (NASDAQ:CBUS) Director Sells $10,258.00 in Stock

Cibus, Inc. (NASDAQ:CBUS) Director Gerhard Prante sold 2,300 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $4.46, for a total transaction of $10,258.00. Following the transaction, the director now directly owns 66,357 shares in the company, valued at approximately $295,952.22. The trade was a 3.35 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Gerhard Prante also recently made the following trade(s):

• On Wednesday, December 4th, Gerhard Prante sold 1,150 shares of Cibus stock. The shares were sold at an average price of $4.39, for a total transaction of $5,048.50.
• On Wednesday, November 27th, Gerhard Prante sold 1,150 shares of Cibus stock. The stock was sold at an average price of $4.50, for a total value of $5,175.00.
• On Monday, November 18th, Gerhard Prante sold 1,150 shares of Cibus stock. The shares were sold at an average price of $4.53, for a total value of $5,209.50.

Cibus Trading Down 2.6 %

Shares of Cibus stock opened at $3.95 on Friday. Cibus, Inc. has a 1 year low of $2.86 and a 1 year high of $23.18. The company’s fifty day simple moving average is $4.03 and its 200-day simple moving average is $7.16. The company has a market cap of $104.38 million, a price-to-earnings ratio of -0.18 and a beta of 1.86.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. FMR LLC increased its stake in Cibus by 16.9% during the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock valued at $12,757,000 after acquiring an additional 566,328 shares during the period. Vanguard Group Inc. raised its stake in shares of Cibus by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock valued at $16,215,000 after buying an additional 26,017 shares in the last quarter. Armistice Capital LLC bought a new position in shares of Cibus during the 2nd quarter worth about $5,083,000. State Street Corp boosted its position in shares of Cibus by 43.6% during the 3rd quarter. State Street Corp now owns 307,262 shares of the company’s stock valued at $1,002,000 after acquiring an additional 93,236 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in Cibus in the second quarter valued at about $529,000. Institutional investors and hedge funds own 33.81% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CBUS shares. HC Wainwright reiterated a “buy” rating and set a $25.00 price target on shares of Cibus in a report on Monday, November 11th. Canaccord Genuity Group reiterated a “buy” rating and issued a $20.00 target price on shares of Cibus in a report on Tuesday, October 22nd. Finally, Alliance Global Partners decreased their price target on shares of Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a report on Tuesday, September 24th.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.